Chemoinformaics analysis of 4-O-cafeoylquinic acid
Molecular Weight | 354.311 | nRot | 4 |
Heavy Atom Molecular Weight | 336.167 | nRig | 15 |
Exact Molecular Weight | 354.095 | nRing | 2 |
Solubility: LogS | -1.512 | nHRing | 0 |
Solubility: LogP | 0.19 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 1 |
nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 9 | No. of Arom Bond | 6 |
nHA | 8 | APOL | 45.9403 |
nHD | 6 | BPOL | 21.5297 |
QED | 0.234 |
Synth | 3.585 |
Natural Product Likeliness | 1.98 |
NR-PPAR-gamma | 0.308 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.628 |
HIA | 0.939 |
CACO-2 | -6.257 |
MDCK | 0.000123607 |
BBB | 0.791 |
PPB | 0.422632 |
VDSS | 0.457 |
FU | 0.470984 |
CYP1A2-inh | 0.168 |
CYP1A2-sub | 0.039 |
CYP2c19-inh | 0.012 |
CYP2c19-sub | 0.047 |
CYP2c9-inh | 0.006 |
CYP2c9-sub | 0.078 |
CYP2d6-inh | 0.014 |
CYP2d6-sub | 0.122 |
CYP3a4-inh | 0.107 |
CYP3a4-sub | 0.036 |
CL | 2.49 |
T12 | 0.922 |
hERG | 0.02 |
Ames | 0.029 |
ROA | 0.047 |
SkinSen | 0.519 |
Carcinogencity | 0.061 |
EI | 0.034 |
Respiratory | 0.05 |
NR-Aromatase | 0.024 |
Antiviral | Yes |
Prediction | 0.765418 |